Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Krispy Kreme Doughnuts (KKD) Earnings: An Early Look

Once known solely for its donuts, Krispy Kreme has moved beyond its former concentration. By introducing healthier items such as yogurt, the company has tried to broaden its appeal and pull in customers looking for more than just a sugar high. That’s been an essential and smart strategy, with competition from rival Dunkin Brands Group Inc (NASDAQ:DNKN) becoming fierce as Dunkin’ has sought to expand its presence in the doughnut-and-coffee space.

One factor that has helped Krispy Kreme is the trend toward consolidation in the coffee and sweets industry. Starbucks Corporation (NASDAQ:SBUX) recently bought Teavana and Tully’s, while private-equity firms have taken out their share of coffee purveyors as well. Krispy Kreme Doughnuts (NYSE:KKD)may not be known for coffee, but its Signature coffee line has helped build coffee loyalty with its customer base, and so the company may look good to a potential acquirer. Yet Krispy Kreme took steps in January to dissuade acquirers by adopting a poison pill, effectively preventing a buyer from taking advantage of its carried-forward net operating losses, which are one of its most valuable assets.

In its quarterly report, watch for Krispy Kreme to discuss its recent expansion move in Taiwan. If the company can boost its international growth, then the stock could enjoy another leg up and regain more of its past glory from its boom years.

The article Krispy Kreme Earnings: An Early Look originally appeared on Fool.com and is written by Dan Caplinger.

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter: @DanCaplinger. The Motley Fool recommends and owns shares of Starbucks.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.